Increasing longevity by decreasing sympathetic stress - Early β receptor blockade pharmacotherapy

Medical Hypotheses

Volumn 62, Issue 5, 2004, Pages 755-758

  Milne, Brian ^a   Hong, M ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACEBUTOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; METOPROLOL; NEBIVOLOL; PINDOLOL;

ADRENERGIC SYSTEM; AGING; ATHEROSCLEROSIS; BLOOD PRESSURE; CARDIOVASCULAR SYSTEM; CONGESTIVE HEART FAILURE; HEART FAILURE; HEART INFARCTION; HEART RATE; HEART SURGERY; HUMAN; HYPERTENSION; LONGEVITY; NONHUMAN; PRIORITY JOURNAL; REVIEW; STRESS; SURVIVAL; SYMPATHETIC TONE; TREATMENT OUTCOME;

EID: 1942467909     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2003.10.027     Document Type: Article

References (28)

1. Rowe JW, Troen BR. Sympathetic nervous system and aging in man. Endocr Rev 1980;1(2):167-79.
2. Esler MD, Thompson JM, Kaye DM, et al. Effects of aging on the responsiveness of the human cardiac sympathetic nerves to stressors. Circulation 1995;91:351-8.
3. Rolzen MF. Should we all have a sympathectomy at birth? Or at least preoperatively? Anesthesiology 1988;68:482-4.
4. Vanderhoff BT, Ruppel HM, Amsterdam PB. Carvedilol: the new role of beta blockers in congestive heart failure. Am Fam Physician 1998;58:1627-34.
5. Constant J. A Review of why and how we may use β-blockers in congestive heart failure. Chest 1998;113:800-8.
6. Mangano DT, Layug EL, Wallace A, Tateo I. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter study of perioperative ischemia research group. N Engl J Med 1996;335:1713-20.
7. Poldermans D, Boersma E, Bax JJ, et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch echocardiographic cardiac risk evaluation applying stress echocardiography study group. N Engl J Med 1999;341:1789-94.
8. Wallace A, Layug B, Tateo I, et al. Prophylactic atenolol reduces postoperative myocardial ischemia. McSPI research group. Anesthesiology 1998;88:7-17.
9. Auerbach AD, Goldman L. Beta-Blockers and reduction of cardiac events in noncardiac surgery: scientific review. JAMA 2002;287:1435-44.
10. Freemantle N, Cleland J, Young P, Mason J, Harrison J. β Blockade after myocardial infarcation: systematic review and meta regression analysis. BMJ 1999;318:1730-7.
11. Viskin S, Barron HV. Beta blockers prevent cardiac death following a myocardial infarction: so why are so many infarct survivors discharged without beta blockers. Am J Cardiol 1996;78(7):821-2.
12. Billinger M, Seiler C, Fleisch M, Eberli FR, Meier B, Hess OM. Do beta-adrenergic blocking agents increase coronary flow reserve. J Am Coll Cardiol 2001;38(7):1866-71.
13. Kaplan JA. Cardiac anesthesia. Cardiovascular pharmacology, vol. 2. New York: Grune and Stratton; 1983.
14. Strawn WB, Bondjers G, Kaplan JR, et al. Endothelial dysfunction in response to psychosocial stress in monkeys. Circ Res 1991;68(5):1270-9.
15. Palda VA, Detsky AS. Perioperative assessment and management of risk from coronary artery disease. Ann Int Med 1997;127:313-28.
16. American College of Physicians. Guidelines for assessing and managing the perioperative risk from coronary artery disease associated with major noncardiac surgery. American College of Physicians. Ann Int Med 1997;127:309-312.
17. Eagle KA, Berger PB, Calkins H, et al. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery - executive summary a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (committee to update the 1996 guidelines on perioperative cardiovascular evaluation for noncardiac surgery). Circulation 2002;105:1257-67.
18. VanDenKerkhof EG, Milne B, Parlow JL. Knowledge and practice regarding prophylactic perioperative beta blockade in patients undergoing noncardiac surgery: a survey of Canadian anesthesiologists. Anesth Analg 2003;96:1558-65.
19. Eichhorn EJ. Restoring function in failing hearts: the effects of beta blockers. The Am J Med 1998;104:163-9.
20. Marks AR. A guide for the perplexed. Towards an understanding of the molecular basis of heart failure. Circulation 2003;107:1456-9.
21. Waagstein F, Bristow MR, Swedberg K, et al. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Lancet 1993;342:1441-6.
22. ver Donck L, Wouters L, Olbrich HG, Mutschler E, Borgers M. Nebivolol increases survival in cardiomyopathic hamsters with congestive heart failure. J Cardiovasc Pharmacol 1991;18(1):1-3.
23. Benetos A, Poitevin P, Prost PL, Safar ME, Levy BI. Life survival and cardiovascular structures following selective β-blockade in spontaneously hypertensive rats. Am J Hypertens 1994;7(2):186-92.
24. Helin P, Lorenzen I, Garbarsch C, Matthiessen ME. Arteriosclerosis in rabbit aorta induced by noradrenaline. Atherosclerosis 1970;12:125-32.
25. Pettersson K, Bejne B, Bjßörk H, Strawn WB, Bondjers G. Experimental sympathetic activation causes endothelial injury in the rabbit thoracic aorta via β-adrenoceptor activation. Circ Res 1990;67:1027-34.
26. Kaplan JR, Manuck SB, Adams MR, Weing KW, Clarkson TB. Inhibition of coronary atherosclerosis by propranolol in behaviorally predisposed monkeys fed on atherogenic diet. Circulation 1987;76(6):1364-72.
27. Wiklund O, Hulthe J, Wikstrand J, Schmidt C, Olofsson SO, Bondjers G. Effect of controlled release/extended release metoprolol on carotid intima-media thickness in patients with hypercholesterolemia. A 3-year randomized study. Stroke 2002;33(2):572-7.
28. Hilakivi LA, Taira A, Hilakivi T, Macdonald I, Tuomisto E, Hellevuo L. Early postnatal treatment with propranolol affects development of brain amines and behavior. Psychopharmacology 1988;96(3):353-9.